{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:15:23Z","timestamp":1790392523941,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jamda.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jamda.2017.02.020","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T13:00:27Z","timestamp":1492520427000},"page":"692-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Antipsychotics and the Risk of Cerebrovascular Accident: A\u00a0Systematic Review and Meta-Analysis of Observational Studies"],"prefix":"10.1016","volume":"18","author":[{"given":"Wan-Ting","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Esmaily-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan","family":"Zala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sie-Huei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shy-Shin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Chang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2017.02.020_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.2082","article-title":"Increasing off-label use of antipsychotic medications in the United States, 1995\u20132008","volume":"20","author":"Alexander","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2017.02.020_bib2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.2011.11010087","article-title":"National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders","volume":"168","author":"Comer","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2017.02.020_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pedhc.2011.10.009","article-title":"Antipsychotic medication prescribing trends in children and adolescents","volume":"26","author":"Harrison","year":"2012","journal-title":"J\u00a0Pediatr Health Care"},{"key":"10.1016\/j.jamda.2017.02.020_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1192\/bjp.bp.111.104257","article-title":"Trends in prescriptions and costs of drugs for mental disorders in England, 1998\u20132010","volume":"200","author":"Ilyas","year":"2012","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jamda.2017.02.020_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archpsyc.63.6.679","article-title":"National trends in the outpatient treatment of children and adolescents with antipsychotic drugs","volume":"63","author":"Olfson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jamda.2017.02.020_bib6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/aje\/kwu210","article-title":"The explanatory role of stroke as a mediator of the mortality risk difference between older adults who initiate first-versus second-generation antipsychotic drugs","volume":"180","author":"Jackson","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jamda.2017.02.020_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCULATIONAHA.114.008779","article-title":"Association between antipsychotic use and risk of acute myocardial infarction: A nationwide case-crossover study","volume":"130","author":"Lin","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jamda.2017.02.020_bib8","doi-asserted-by":"crossref","first-page":"647476","DOI":"10.1155\/2013\/647476","article-title":"Risk of mortality (including sudden cardiac death) and major cardiovascular events in users of olanzapine and other antipsychotics: A study with the General Practice Research Database","volume":"2013","author":"Jones","year":"2013","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"10.1016\/j.jamda.2017.02.020_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jagp.2013.06.007","article-title":"Short-and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: A population-based study","volume":"22","author":"Langballe","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2017.02.020_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2017.02.020_bib11","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa052827","article-title":"Risk of death in elderly users of conventional vs atypical antipsychotic medications","volume":"353","author":"Wang","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2017.02.020_bib12","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2017.02.020_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/pds.1334","article-title":"All-cause mortality associated with atypical and typical antipsychotics in demented outpatients","volume":"16","author":"Trifir\u00f2","year":"2007","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1016\/j.jamda.2017.02.020_bib14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2165\/00002512-200522100-00004","article-title":"Antipsychotics for behavioural and psychological problems in elderly people with dementia","volume":"22","author":"van Iersel","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2017.02.020_bib15","doi-asserted-by":"crossref","first-page":"e105376","DOI":"10.1371\/journal.pone.0105376","article-title":"Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: Systematic review and meta-synthesis","volume":"9","author":"Jackson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2017.02.020_bib16","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1532-5415.2011.03479.x","article-title":"Risk of cerebrovascular accident associated with use of antipsychotics: Population-based case-control study","volume":"59","author":"Laredo","year":"2011","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2017.02.020_bib17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.biopsych.2012.07.006","article-title":"Association of stroke with the receptor-binding profiles of antipsychotics\u2014A case-crossover study","volume":"73","author":"Wu","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jamda.2017.02.020_bib18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/0269881113482530","article-title":"Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: A population-based, case-crossover study","volume":"27","author":"Shin","year":"2013","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jamda.2017.02.020_bib19","doi-asserted-by":"crossref","first-page":"e61771","DOI":"10.1371\/journal.pone.0061771","article-title":"Population-based 5-year follow-up study in Taiwan of dementia and risk of stroke","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2017.02.020_bib20","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/11584490-000000000-00000","article-title":"Risk of hospitalization for stroke associated with antipsychotic use in the elderly","volume":"27","author":"Pratt","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2017.02.020_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/wps.20187","article-title":"Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a nonelderly adult sample: Results from a claims-based inception cohort study","volume":"14","author":"Correll","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jamda.2017.02.020_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/01.jcp.0000178414.14685.c4","article-title":"Second-generation antipsychotics and risk of cerebrovascular accidents in the elderly","volume":"25","author":"Percudani","year":"2005","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jamda.2017.02.020_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.38330.470486.8F","article-title":"Atypical antipsychotic drugs and risk of ischaemic stroke: Population-based retrospective cohort study","volume":"330","author":"Gill","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2017.02.020_bib24","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1176\/appi.ajp.161.6.1113","article-title":"Atypical antipsychotics and risk of cerebrovascular accidents","volume":"161","author":"Herrmann","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2017.02.020_bib25","first-page":"495","article-title":"Cardiovascular risk factors in chronic treatment with antipsychotic agents used in primary care","volume":"57","author":"Mundet-Tudur\u00ed","year":"2013","journal-title":"Rev Neurol"},{"key":"10.1016\/j.jamda.2017.02.020_bib26","doi-asserted-by":"crossref","unstructured":"US F. FDA requests Boxed Warnings on conventional antipsychotics. Secondary FDA requests Boxed Warnings on conventional antipsychotics 2008. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2008\/ucm116912.htm. Accessed November 1, 2016.","DOI":"10.2165\/00128415-200812070-00001"},{"key":"10.1016\/j.jamda.2017.02.020_bib27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7326\/0003-4819-157-7-201210020-00525","article-title":"Antipsychotics in adults with schizophrenia: Comparative effectiveness of first-generation versus second-generation medications: A systematic review and meta-analysis","volume":"157","author":"Hartling","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2017.02.020_bib28","doi-asserted-by":"crossref","unstructured":"U.S. F. Information on Conventional Antipsychotics. Secondary Information on Conventional Antipsychotics 2008. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm107211.htm. Accessed November 1, 2016.","DOI":"10.2165\/00128415-200812070-00001"},{"key":"10.1016\/j.jamda.2017.02.020_bib29","unstructured":"FDA US. Atypical Antipsychotic Drugs Information. Secondary Atypical Antipsychotic Drugs Information. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm094303.htm. Accessed November 1, 2016."},{"key":"10.1016\/j.jamda.2017.02.020_bib30","unstructured":"Wells GA, O'Connell D, Peterson J, et\u00a0al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Secondary The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"10.1016\/j.jamda.2017.02.020_bib31","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies","volume":"22","author":"Mantel","year":"1959","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jamda.2017.02.020_bib32","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.jamda.2017.02.020_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2017.02.020_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A\u00a0basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jamda.2017.02.020_bib35","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ejvs.2010.07.011","article-title":"Quality control in systematic reviews and meta-analyses","volume":"40","author":"Bown","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jamda.2017.02.020_bib36","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/0269881108093583","article-title":"Risk of cerebrovascular events in elderly users of antipsychotics","volume":"23","author":"Kleijer","year":"2009","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jamda.2017.02.020_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/JCP.0b013e3182900dfe","article-title":"Use of antipsychotics and risk of cerebrovascular events in schizophrenic patients: A nested case-control study","volume":"33","author":"Hsieh","year":"2013","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jamda.2017.02.020_bib38","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4088\/JCP.v66n0901","article-title":"Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics","volume":"66","author":"Liperoti","year":"2005","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jamda.2017.02.020_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0269881107080792","article-title":"Risk of stroke with typical and atypical anti-psychotics: A retrospective cohort study including unexposed subjects","volume":"22","author":"Sacchetti","year":"2008","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jamda.2017.02.020_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/STROKEAHA.111.617191","article-title":"Age, antipsychotics, and the risk of ischemic stroke in the Veterans Health Administration","volume":"43","author":"Wang","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jamda.2017.02.020_bib41","doi-asserted-by":"crossref","first-page":"a1227","DOI":"10.1136\/bmj.a1227","article-title":"Exposure to antipsychotics and risk of stroke: Self-controlled case series study","volume":"337","author":"Douglas","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2017.02.020_bib42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/gps.2347","article-title":"Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: A hospital-based, retrospective, cohort study","volume":"25","author":"Chan","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2017.02.020_bib43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/11319120-000000000-00000","article-title":"Cerebrovascular accidents in elderly people treated with antipsychotic drugs","volume":"33","author":"Sacchetti","year":"2010","journal-title":"Drug Safety"},{"key":"10.1016\/j.jamda.2017.02.020_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-12-72","article-title":"Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: A systematic review","volume":"12","author":"Pratt","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jamda.2017.02.020_bib45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/ene.12325","article-title":"Estimating the burden of early onset dementia; Systematic review of disease prevalence","volume":"21","author":"Lambert","year":"2014","journal-title":"Eur J Neurol"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861017301299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861017301299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T05:40:58Z","timestamp":1569044458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861017301299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1525861017301299"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2017.02.020","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotics and the Risk of Cerebrovascular Accident: A\u00a0Systematic Review and Meta-Analysis of Observational Studies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2017.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}